Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
The Journal of Investigative Dermatology
|
February 11, 2014
The oncogene ATF3 is potentiated by cyclosporine A and ultraviolet light A
Piotr J Dziunycz, Karine Lefort, Xunwei Wu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 31, 2024
Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [<sup>68</sup>Ga]Ga-PSMA-11 PET scans of primary prostate cancer
Niels J Rupp, Sandra N Freiberger, Daniela A Ferraro, et al.
Oncotarget
|
October 30, 2016
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance
Marieke I G Raaijmakers, Daniel S Widmer, Apurva Narechania, et al.
Oncotarget
|
December 6, 2019
Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2<sup>S310F</sup> mutated extramammary Paget's disease
Thierry M Nordmann, Olivia Messerli-Odermatt, Larissa Meier, et al.
Molecular Cancer Therapeutics
|
June 28, 2015
Ingenol Mebutate Signals via PKC/MEK/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2
Sandra N Freiberger, Phil F Cheng, Guergana Iotzova-Weiss, et al.
Journal of Cancer Research and Clinical Oncology
|
January 27, 2026
Metastatic and recurrent salivary gland carcinoma: clinical characteristics and comprehensive molecular profiling at a tertiary care center
Tamara Rordorf, Panagiotis Balermpas, Tomas Brezina, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 30, 2018
Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling
Deborah S Leuthard, Agathe Duda, Sandra N Freiberger, et al.
Histopathology
|
June 26, 2024
Expanding the spectrum of low-grade sinonasal adenocarcinoma with biphasic seromucinous differentiation and activating HRAS/AKT1 mutations
Viktoria S Hadnagy, Meike Körner, Matthias Rössle, et al.
Pathology, Research and Practice
|
March 28, 2018
Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study
Nadezda P Velizheva, Markus P Rechsteiner, Nadejda Valtcheva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2025
Circulating tumor DNA is prognostic of patient outcome and enables therapy monitoring in metastatic uveal melanoma
Egle Ramelyte, Julian Kött, Aleigha R Lawless, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
The Journal of Investigative Dermatology
|
February 11, 2014
The oncogene ATF3 is potentiated by cyclosporine A and ultraviolet light A
Piotr J Dziunycz, Karine Lefort, Xunwei Wu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 31, 2024
Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [<sup>68</sup>Ga]Ga-PSMA-11 PET scans of primary prostate cancer
Niels J Rupp, Sandra N Freiberger, Daniela A Ferraro, et al.
Oncotarget
|
October 30, 2016
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance
Marieke I G Raaijmakers, Daniel S Widmer, Apurva Narechania, et al.
Oncotarget
|
December 6, 2019
Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2<sup>S310F</sup> mutated extramammary Paget's disease
Thierry M Nordmann, Olivia Messerli-Odermatt, Larissa Meier, et al.
Molecular Cancer Therapeutics
|
June 28, 2015
Ingenol Mebutate Signals via PKC/MEK/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2
Sandra N Freiberger, Phil F Cheng, Guergana Iotzova-Weiss, et al.
Journal of Cancer Research and Clinical Oncology
|
January 27, 2026
Metastatic and recurrent salivary gland carcinoma: clinical characteristics and comprehensive molecular profiling at a tertiary care center
Tamara Rordorf, Panagiotis Balermpas, Tomas Brezina, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 30, 2018
Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling
Deborah S Leuthard, Agathe Duda, Sandra N Freiberger, et al.
Histopathology
|
June 26, 2024
Expanding the spectrum of low-grade sinonasal adenocarcinoma with biphasic seromucinous differentiation and activating HRAS/AKT1 mutations
Viktoria S Hadnagy, Meike Körner, Matthias Rössle, et al.
Pathology, Research and Practice
|
March 28, 2018
Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study
Nadezda P Velizheva, Markus P Rechsteiner, Nadejda Valtcheva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2025
Circulating tumor DNA is prognostic of patient outcome and enables therapy monitoring in metastatic uveal melanoma
Egle Ramelyte, Julian Kött, Aleigha R Lawless, et al.
Page
of 6